Land: Australië
Taal: Engels
Bron: Department of Health (Therapeutic Goods Administration)
irbesartan, Quantity: 300 mg; hydrochlorothiazide, Quantity: 25 mg
Alembic Pharmaceuticals Australia Pty Ltd
Hydrochlorothiazide,Irbesartan
Tablet, film coated
Excipient Ingredients: magnesium stearate; croscarmellose sodium; lactose monohydrate; povidone; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black
Oral
30s
(S4) Prescription Only Medicine
For the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination.
Visual Identification: Pinkish brown, oval shaped, biconvex, film coated tablet, debossed with "L185" on one side and plain on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2012-11-13